RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Bacteremia
Accession: DOID:9005036
browse the term
Definition: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
Synonyms: exact_synonym: BACTS1; BACTS2; Bacteremias; bacteriemia
narrow_synonym: non-typhoidal Salmonella bacteremia
related_synonym: Bacteremia, Resistance To; bacteremia, susceptibility to, 1; bacteremia, susceptibility to, 2
primary_id: MESH:D016470
alt_id: OMIM:614382 ; OMIM:614383
xref: EFO:0003033 ; EFO:0009087
GViewer not supported for the selected species.
G
CCL2
C-C motif chemokine ligand 2
ISO
associated with Febrile Neutropenia;protein:increased expression:serum (human)
RGD
PMID:22584776
RGD:11528568
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
G
CEBPB
CCAAT enhancer binding protein beta
ISO
associated with alcohol use disorder;mRNA:increased expression:bone marrow (mouse)
RGD
PMID:28784931
RGD:40903040
NCBI chr 2:13,780,538...13,782,639
Ensembl chr 2:13,781,160...13,782,194
G
CFH
complement factor H
ISO
associated with Meningococcal Infections;
RGD
PMID:22104107
RGD:7364945
NCBI chr25:32,557,697...32,744,763
G
CISH
cytokine inducible SH2 containing protein
susceptibility
ISO
ClinVar Annotator: match by term: Bacteremia, susceptibility to, 2
OMIM ClinVar
PMID:20484391
NCBI chr22:11,993,212...11,998,625
Ensembl chr22:11,993,242...11,995,375
G
CPB2
carboxypeptidase B2
ISO
protein:decreased activity:plasma
RGD
PMID:17911187
RGD:2313646
NCBI chr 3:24,108,854...24,161,669
Ensembl chr 3:24,109,416...24,161,408
G
CRP
C-reactive protein
ISO
protein:increased expression:serum:
RGD
PMID:18443549
RGD:9491402
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
G
CSF2
colony stimulating factor 2
treatment
ISO
RGD
PMID:2192004
RGD:10449532
NCBI chr23:34,906,987...34,911,252
Ensembl chr23:34,908,911...34,911,140
G
FCGR2A
Fc fragment of IgG receptor IIa
ISO
associated with Pneumonia;DNA:SNP: :p.H131R (rs1801274) (human)
RGD
PMID:21317643
RGD:5147986
NCBI chr20:2,480,710...2,512,429
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
severity
ISO
RGD
PMID:11565076
RGD:5508478
NCBI chr 4:69,664,784...69,690,343
Ensembl chr 4:69,665,417...69,688,686
G
ICAM1
intercellular adhesion molecule 1
ISO
mRNA:increased expression:lung,thymus,spleen:
RGD
PMID:24891762
RGD:11354979
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
G
IL17A
interleukin 17A
ISO
associated with Respiratory Distress Syndrome, Adult; protein:increased expression:serum
RGD
PMID:21062445
RGD:5128683
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
G
IL27
interleukin 27
ISO
protein:increased expression:blood serum (human)
RGD
PMID:26514771
RGD:126790515
NCBI chr 5:26,348,559...26,358,028
Ensembl chr 5:26,348,848...26,356,360
G
ITIH4
inter-alpha-trypsin inhibitor heavy chain 4
ISO
protein:increased expression:liver, serum
RGD
PMID:33348064
RGD:40907057
NCBI chr22:14,194,979...14,216,180
Ensembl chr22:14,195,701...14,213,603
G
MAPKAPK3
MAPK activated protein kinase 3
ISO
ClinVar Annotator: match by term: Bacteremia, susceptibility to, 2
ClinVar
PMID:20484391
NCBI chr22:11,998,774...12,036,477
G
MBL2
mannose binding lectin 2
treatment
ISO
associated with Multiple Myeloma:DNA:polymorphism:exon:
RGD
PMID:16953214
RGD:11530047
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
G
NOD2
nucleotide binding oligomerization domain containing 2
severity
ISO
associated with Staphylococcal Infections;
RGD
PMID:24086711
RGD:13204726
NCBI chr 5:36,492,158...36,531,766
Ensembl chr 5:36,496,414...36,530,499
G
PLAT
plasminogen activator, tissue type
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1430592
NCBI chr 8:40,164,391...40,196,627
Ensembl chr 8:40,163,891...40,196,555
G
PLAUR
plasminogen activator, urokinase receptor
severity
ISO
RGD
PMID:21332843
RGD:6483799
NCBI chr 6:37,161,957...37,191,867
G
SERPINC1
serpin family C member 1
treatment
ISO
RGD
PMID:2679067
RGD:11035251
NCBI chr25:55,271,823...55,289,855
G
SOD2
superoxide dismutase 2
ISO
mRNA:increased expression:liver:
RGD
PMID:24253037
RGD:26923958
NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
G
TIRAP
TIR domain containing adaptor protein
ISO
ClinVar Annotator: match by term: Bacteremia, susceptibility to, 1
OMIM ClinVar
PMID:16991088 PMID:17322885 PMID:18305471 PMID:25741868
NCBI chr 1:117,417,561...117,419,870
G
TLR4
toll like receptor 4
susceptibility
ISO
DNA:polymorphisms:cds:p.D299G, T399I (human)
RGD
PMID:18180796
RGD:4144194
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
G
ABCB1
ATP binding cassette subfamily B member 1
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:26977098
RGD:11041000
NCBI chr21:61,211,044...61,430,691
Ensembl chr21:61,322,748...61,529,274
G
ABCB11
ATP binding cassette subfamily B member 11
ISO
RGD
PMID:9828229
RGD:1598596
NCBI chr10:54,458,283...54,575,943
Ensembl chr10:54,459,377...54,575,059
G
ABCC2
ATP binding cassette subfamily C member 2
ISO
RGD
PMID:16572733
RGD:1598611
NCBI chr 9:92,826,423...92,902,389
Ensembl chr 9:92,841,818...92,902,265
G
ABCC8
ATP binding cassette subfamily C member 8
ISO
RGD
PMID:17285300
RGD:2301914
NCBI chr 1:47,494,861...47,578,818
Ensembl chr 1:47,494,959...47,578,882
G
ACHE
acetylcholinesterase (Cartwright blood group)
ISO
RGD
PMID:17657467
RGD:5688055
NCBI chr28:12,328,304...12,335,302
Ensembl chr28:12,331,039...12,335,076
G
ACTC1
actin alpha cardiac muscle 1
ISO
RGD
PMID:11680626
RGD:1598729
NCBI chr26:48,105,271...48,110,670
Ensembl chr26:48,105,216...48,110,896
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
protein:increased expression:plasma, spleen
RGD
PMID:23025351
RGD:9681752
NCBI chr 2:65,376,288...65,385,398
Ensembl chr 2:65,376,310...65,385,918
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
associated with Obesity
RGD
PMID:23838384
RGD:8695926
NCBI chr15:81,128,427...81,142,779
Ensembl chr15:81,129,795...81,147,391
G
ADIPOR2
adiponectin receptor 2
severity
ISO
associated with obesity;mRNA:decreased expression:liver (rat)
RGD
PMID:23838384
RGD:8695926
NCBI chr11:1,802,694...1,836,703
Ensembl chr11:1,738,026...1,837,060
G
ADRA2A
adrenoceptor alpha 2A
onset
ISO
mRNA:increased expression:spleen
RGD
PMID:20302880
RGD:6480487
NCBI chr 9:104,015,577...104,019,364
Ensembl chr 9:104,016,580...104,017,932
G
AGTR2
angiotensin II receptor type 2
ISO
protein:decreased expression:kidney
RGD
PMID:16725227
RGD:6903849
G
AHR
aryl hydrocarbon receptor
severity
ISO
RGD
PMID:24930766
RGD:39939032
NCBI chr21:40,778,198...40,826,491
Ensembl chr21:40,778,218...40,826,478
G
AKT1
AKT serine/threonine kinase 1
ISO
RGD
PMID:22824368
RGD:38676479
NCBI chr24:82,704,087...82,730,711
Ensembl chr24:82,704,068...82,727,698
G
ALDOA
aldolase, fructose-bisphosphate A
ISO
RGD
PMID:16930621
RGD:1599054
Ensembl chr 5:26,588,868...26,592,112
G
ALOX5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15328337
NCBI chr 9:41,085,257...41,145,760
Ensembl chr 9:41,085,361...41,145,331
G
APOA1
apolipoprotein A1
treatment
ISO
RGD
PMID:18593575 PMID:23227448
RGD:7241573 RGD:7241868
NCBI chr 1:108,201,967...108,203,902
Ensembl chr 1:108,201,439...108,203,609
G
APOB
apolipoprotein B
ISO
RGD
PMID:16719989
RGD:1599165
NCBI chr14:86,624,209...86,669,175
Ensembl chr14:86,624,332...86,668,704
G
APOE
apolipoprotein E
ISO
rat model treated with human protein
RGD
PMID:9153287
RGD:6904216
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
ASL
argininosuccinate lyase
ISO
RGD
PMID:10652239
RGD:1599265
NCBI chr28:1,782,434...1,800,581
Ensembl chr28:1,782,553...1,802,517
G
ASS1
argininosuccinate synthase 1
ISO
RGD
PMID:10652239
RGD:1599265
NCBI chr12:7,643,484...7,701,334
G
ATF2
activating transcription factor 2
treatment
ISO
protein:increased expression, increased activity:small intestine mucosa
RGD
PMID:21641970 PMID:24312512
RGD:10047418 RGD:5135029
NCBI chr10:60,644,623...60,734,465
Ensembl chr10:60,644,635...60,734,475
G
ATP5F1A
ATP synthase F1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr18:34,815,924...34,828,052
Ensembl chr18:34,816,027...34,830,924
G
BAX
BCL2 associated X, apoptosis regulator
ISO
mRNA:increased expression:diaphragm
RGD
PMID:23940949
RGD:10054120
NCBI chr 6:42,186,028...42,193,105
G
BCHE
butyrylcholinesterase
ISO
RGD
PMID:17657467
RGD:5688055
NCBI chr15:23,708,121...23,778,027
Ensembl chr15:23,708,155...23,778,286
G
BCL2
BCL2 apoptosis regulator
ISO
mRNA:decreased expression:diaphragm
RGD
PMID:23940949
RGD:10054120
NCBI chr18:16,440,560...16,643,187
Ensembl chr18:16,441,733...16,637,895
G
C5AR1
complement C5a receptor 1
ISO
mRNA:increased expression:lung
RGD
PMID:9272704
RGD:70679
NCBI chr 6:40,633,540...40,651,839
Ensembl chr 6:40,633,448...40,652,845
G
CASP1
caspase 1
ISO
RGD
PMID:17384935
RGD:2315892
NCBI chr 1:96,389,697...96,400,610
Ensembl chr 1:96,389,657...96,400,849
G
CASP3
caspase 3
ISO
mRNA:increased expression:diaphragm
RGD
PMID:23940949
RGD:10054120
NCBI chr 7:130,589,592...130,610,845
Ensembl chr 7:130,591,166...130,610,899
G
CASP7
caspase 7
ISO
RGD
PMID:19168786
RGD:5684539
NCBI chr 9:106,558,291...106,607,662
Ensembl chr 9:106,559,445...106,607,663
G
CASP9
caspase 9
treatment
ISO
RGD
PMID:23214195
RGD:10400903
NCBI chr20:116,772,819...116,798,402
Ensembl chr20:116,772,155...116,798,930
G
CCL2
C-C motif chemokine ligand 2
ISO
protein:increased expression:plasma
RGD
PMID:19060786
RGD:2307004
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
G
CCL5
C-C motif chemokine ligand 5
ISO
protein:increased expression:plasma
RGD
PMID:16215387
RGD:2307171
NCBI chr16:29,351,214...29,361,317
G
CCR1
C-C motif chemokine receptor 1
ISO
RGD
PMID:17016504
RGD:5688178
NCBI chr22:7,634,205...7,641,380
G
CD14
CD14 molecule
ISO
protein:increased expression:liver, endothelial cell of sinusoid
RGD
PMID:12046090
RGD:724637
NCBI chr23:43,264,917...43,266,825
Ensembl chr23:43,264,336...43,266,993
G
CD40
CD40 molecule
ISO
protein:decreased nitrosylation:macrophage
RGD
PMID:20473113
RGD:5490974
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
G
CEBPB
CCAAT enhancer binding protein beta
treatment
ISO
RGD
PMID:14659593 PMID:15192048
RGD:1625687 RGD:40903034
NCBI chr 2:13,780,538...13,782,639
Ensembl chr 2:13,781,160...13,782,194
G
CPS1
carbamoyl-phosphate synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr10:96,267,890...96,392,393
Ensembl chr10:96,267,889...96,392,206
G
CS
citrate synthase
ISO
protein:increased expression:gastrocnemius
RGD
PMID:25674200
RGD:329337350
NCBI chr11:52,224,667...52,253,552
Ensembl chr11:52,222,724...52,253,307
G
CSF3
colony stimulating factor 3
treatment
ISO
RGD
PMID:9514298
RGD:11039535
NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
mRNA:increased expression:multiple organs
RGD
PMID:9766630
RGD:5135254
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
G
CXCL6
C-X-C motif chemokine ligand 6
ISO
mRNA:increased expression:multiple organs
RGD
PMID:9766630
RGD:5135254
NCBI chr 7:22,291,949...22,294,191
Ensembl chr 7:22,292,045...22,294,207
G
EDN1
endothelin 1
ISO
mRNA, protein:increased expression:liver (rat)
RGD
PMID:11206318
RGD:8662297
NCBI chr17:59,854,186...59,861,319
Ensembl chr17:59,853,699...59,861,198
G
EP300
E1A binding protein p300
ISO
associated with Kidney Reperfusion Injury; protein:altered localization:kidney (rat)
RGD
PMID:23936185
RGD:7257563
NCBI chr19:23,634,132...23,726,095
Ensembl chr19:23,634,571...23,724,979
G
EPHX2
epoxide hydrolase 2
ISO
RGD
PMID:19154430
RGD:5688360
NCBI chr 8:25,603,668...25,659,232
Ensembl chr 8:25,603,735...25,659,345
G
EPO
erythropoietin
treatment
ISO
RGD
PMID:23214195
RGD:10400903
NCBI chr28:12,487,222...12,491,986
Ensembl chr28:12,489,766...12,491,908
G
F12
coagulation factor XII
ISO
RGD
PMID:11092686
RGD:7394782
NCBI chr23:79,414,074...79,438,896
Ensembl chr23:79,414,225...79,432,298
G
F3
coagulation factor III, tissue factor
treatment
ISO
associated with Protein C Deficiency
RGD
PMID:8956768 PMID:20858853 PMID:21396682
RGD:11340208 RGD:11341685 RGD:5147765
NCBI chr20:38,726,690...38,738,457
Ensembl chr20:38,726,798...38,739,408
G
F5
coagulation factor V
ISO
RGD
PMID:11092686
RGD:7394782
NCBI chr25:59,465,610...59,539,022
Ensembl chr25:59,466,378...59,538,872
G
F7
coagulation factor VII
treatment
ISO
RGD
PMID:11092686 PMID:16378835
RGD:11041650 RGD:7394782
NCBI chr 3:91,109,864...91,122,707
Ensembl chr 3:91,110,380...91,123,327
G
F8
coagulation factor VIII
ISO
RGD
PMID:11092686
RGD:7394782
NCBI chr X:129,090,140...129,315,343
Ensembl chr X:129,088,611...129,312,909
G
FGA
fibrinogen alpha chain
treatment
ISO
RGD
PMID:19295478
RGD:11040925
NCBI chr 7:101,127,554...101,134,881
Ensembl chr 7:101,125,791...101,134,405
G
FOXP3
forkhead box P3
ISO
protein:increased expression:intestinal mucosa
RGD
PMID:19998507
RGD:38455980
NCBI chr X:46,349,890...46,365,133
G
GCH1
GTP cyclohydrolase 1
treatment
ISO
mRNA:increased expression:lung associated with liver cirrhosis
RGD
PMID:9388472 PMID:14647062 PMID:16845913
RGD:329961576 RGD:401700399 RGD:401793756
NCBI chr24:32,029,997...32,079,656
Ensembl chr24:32,027,648...32,079,490
G
GFER
growth factor, augmenter of liver regeneration
ISO
RGD
PMID:23073658
RGD:9685733
NCBI chr 5:1,880,025...1,886,829
Ensembl chr 5:1,879,968...1,883,696
G
GHR
growth hormone receptor
ISO
mRNA:decreased expression:liver
RGD
PMID:12217886 PMID:12654216
RGD:2307380 RGD:625688
NCBI chr 4:41,171,038...41,464,474
Ensembl chr 4:41,285,712...41,464,666
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:25514429
RGD:401717525
NCBI chr 8:138,716,802...138,721,421
Ensembl chr 8:138,718,767...138,721,251
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:25469663
RGD:10401928
NCBI chr 8:28,778,713...28,851,907
G
HMGB1
high mobility group box 1
ISO
protein:increased expression:heart, serum
RGD
PMID:18503231
RGD:10402065
NCBI chr 3:9,353,333...9,357,765
G
HMOX1
heme oxygenase 1
treatment
ISO
RGD
PMID:21396999
RGD:10755715
NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
G
HSF1
heat shock transcription factor 1
treatment
ISO
RGD
PMID:25571843
RGD:10402404
NCBI chr 8:138,503,836...138,529,562
Ensembl chr 8:138,503,831...138,529,165
G
HSPA9
heat shock protein family A (Hsp70) member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr23:41,230,675...41,251,177
Ensembl chr23:41,231,364...41,251,150
G
HSPD1
heat shock protein family D (Hsp60) member 1
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:medulla oblongata
CTD RGD
PMID:16675490 PMID:16741687
RGD:1624232
NCBI chr10:83,003,266...83,017,397
Ensembl chr10:83,003,717...83,017,363
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased expression:lung (rat)
RGD
PMID:19776691
RGD:4145502
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
G
IDO1
indoleamine 2,3-dioxygenase 1
ISO
RGD
PMID:24930766 PMID:28077574
RGD:39939032 RGD:39939117
NCBI chr 8:37,930,910...37,950,790
Ensembl chr 8:37,930,562...37,946,505
G
IDO2
indoleamine 2,3-dioxygenase 2
ISO
RGD
PMID:24930766
RGD:39939032
NCBI chr 8:37,951,810...38,027,689
Ensembl chr 8:37,959,078...38,027,632
G
IFNG
interferon gamma
ISO
protein:increased expression:serum:
RGD
PMID:9195172
RGD:10755747
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
G
IGF1
insulin like growth factor 1
ISO
mRNA, protein:decreased expression:liver, serum
RGD
PMID:12217886 PMID:18492809
RGD:10402757 RGD:625688
NCBI chr11:97,624,498...97,708,730
Ensembl chr11:97,631,189...97,707,308
G
IGFALS
insulin like growth factor binding protein acid labile subunit
ISO
RGD
PMID:12217886
RGD:625688
NCBI chr 5:1,698,787...1,704,205
Ensembl chr 5:1,698,978...1,701,972
G
IGFBP1
insulin like growth factor binding protein 1
ISO
RGD
PMID:12217886
RGD:625688
NCBI chr21:12,932,727...12,939,078
Ensembl chr21:12,932,732...12,937,891
G
IGFBP3
insulin like growth factor binding protein 3
ISO
mRNA, protein:decreased expression:liver, serum
RGD
PMID:18492809
RGD:10402757
NCBI chr21:12,905,309...12,914,199
Ensembl chr21:12,905,280...12,914,205
G
IGFBP5
insulin like growth factor binding protein 5
ISO
RGD
PMID:12217886
RGD:625688
NCBI chr10:102,510,939...102,531,710
Ensembl chr10:102,510,897...102,531,724
G
IL10
interleukin 10
treatment
ISO
protein:increased expression:plasma
RGD
PMID:19302852 PMID:27943364 PMID:28664613
RGD:14975137 RGD:14975170 RGD:2311055
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
IL13
interleukin 13
treatment
ISO
RGD
PMID:10674721
RGD:8549626
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
G
IL1A
interleukin 1 alpha
ISO
protein:increased expression:plasma
RGD
PMID:9636192 PMID:22426124
RGD:6907109 RGD:7794786
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:plasma
RGD
PMID:17201737
RGD:1626625
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
mRNA:increased expression:lung, spleen, liver (rat)
RGD
PMID:1385928 PMID:8855299
RGD:11522760 RGD:8551846
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
G
IL6
interleukin 6
ISO
protein:increased expression:serum (rat) associated with Diabetes Mellitus, Experimental; Protein:increased expression:extracellular space (rat)
RGD
PMID:19449282 PMID:21396682 PMID:22227956
RGD:2307179 RGD:5147765 RGD:6893482
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
G
IRAK3
interleukin 1 receptor associated kinase 3
ISO
mRNA, protein:increased expression:blood (human)
RGD
PMID:17982103
RGD:36049802
NCBI chr11:61,868,817...61,920,896
Ensembl chr11:61,869,173...61,920,406
G
IRS1
insulin receptor substrate 1
ISO
protein:increased tyrosine nitration, decreased tyrosine phosphorylation:skeletal muscle
RGD
PMID:21206533
RGD:6483008
NCBI chr10:112,748,283...112,812,368
G
ITGA2B
integrin subunit alpha 2b
ISO
RGD
PMID:15280099
RGD:2316360
NCBI chr16:62,001,082...62,019,470
Ensembl chr16:62,001,352...62,019,289
G
ITGB3
integrin subunit beta 3
ISO
RGD
PMID:15280099
RGD:2316360
NCBI chr16:59,372,171...59,431,434
Ensembl chr16:59,374,889...59,410,857
G
KEAP1
kelch like ECH associated protein 1
ISO
RGD
PMID:22609006
RGD:6892951
NCBI chr 6:9,515,789...9,526,699
Ensembl chr 6:9,515,416...9,522,797
G
LBP
lipopolysaccharide binding protein
treatment
ISO
mRNA:increased expression:hepatocyte
RGD
PMID:8418776 PMID:8593028 PMID:16307218
RGD:9685191 RGD:9685193 RGD:9685196
NCBI chr 2:25,375,364...25,407,181
Ensembl chr 2:25,374,755...25,406,839
G
LCN2
lipocalin 2
ISO
mRNA:increased expression:brain,liver
RGD
PMID:21943033
RGD:126779582
NCBI chr12:9,976,278...9,981,087
Ensembl chr12:9,976,614...9,980,870
G
LOC103221104
cystathionine beta-synthase
severity
ISO
mRNA:increased expression:liver (rat) Protein:increased expression:spleen, lung (mouse)
RGD
PMID:16100527 PMID:24702258 PMID:27748832
RGD:40903019 RGD:40903035 RGD:40903049
NCBI chr 2:86,905,104...86,933,780
G
LOC103231478
myosin-6
ISO
RGD
PMID:7874842
RGD:12792976
NCBI chr29:23,753,251...23,780,822
Ensembl chr29:23,753,309...23,778,107
G
LOC103231480
myosin-7
ISO
RGD
PMID:7874842
RGD:12792976
NCBI chr29:23,783,610...23,804,981
Ensembl chr29:23,783,557...23,799,771
G
LOC103233058
fractalkine
ISO
protein:increased expression:atrium endocardium
RGD
PMID:19282612
RGD:4891965
NCBI chr 5:43,310,711...43,323,533
Ensembl chr 5:43,310,753...43,323,529
G
LOC103233689
thromboxane A2 receptor
ISO
RGD
PMID:2580129 PMID:15647606
RGD:11059531 RGD:1601450
NCBI chr 6:3,354,358...3,365,779
Ensembl chr 6:3,355,314...3,359,761
G
LOC103243413
signal transducer and activator of transcription 5B
ISO
protein:decreased tyrosine phosphorylation:liver
RGD
PMID:17327369
RGD:1601383
NCBI chr16:63,997,486...64,070,392
Ensembl chr16:63,997,441...64,070,445
G
MAP2
microtubule associated protein 2
ISO
mRNA, protein:decreased expression:neuron
RGD
PMID:21421895
RGD:6483086
NCBI chr10:95,319,649...95,431,106
Ensembl chr10:95,349,157...95,431,320
G
MAPK14
mitogen-activated protein kinase 14
treatment
ISO
protein:increased activity:small intestine mucosa
RGD
PMID:21641970 PMID:24312512
RGD:10047418 RGD:5135029
NCBI chr17:36,012,164...36,095,542
Ensembl chr17:36,014,454...36,095,138
G
MAPK8
mitogen-activated protein kinase 8
ISO
protein:increased phophorylation:hippocampus (rat)
RGD
PMID:12207162
RGD:150340687
NCBI chr 9:43,356,603...43,489,066
Ensembl chr 9:43,356,308...43,393,425
G
MC4R
melanocortin 4 receptor
ISO
mRNA:increased expression:paraventricular nucleus (rat)
RGD
PMID:21343543
RGD:6484214
NCBI chr18:19,380,054...19,386,412
Ensembl chr18:19,380,849...19,381,847
G
MIF
macrophage migration inhibitory factor
ISO
protein:increased expression:plasma
RGD
PMID:16601957
RGD:1641983
NCBI chr19:7,000,837...7,001,700
Ensembl chr19:7,000,793...7,001,757
G
MME
membrane metalloendopeptidase
severity
ISO
RGD
PMID:11078421
RGD:13801040
NCBI chr15:35,577,460...35,681,730
Ensembl chr15:35,580,714...35,633,914
G
MMP3
matrix metallopeptidase 3
ISO
RGD
PMID:17083784
RGD:2290426
NCBI chr 1:94,216,156...94,224,437
Ensembl chr 1:94,216,173...94,224,264
G
MT3
metallothionein 3
ISO
RGD
PMID:12135776
RGD:10412330
NCBI chr 5:42,502,306...42,504,467
G
MUC2
mucin 2, oligomeric mucus/gel-forming
ISO
RGD
PMID:19099858
RGD:7349370
NCBI chr 1:893,554...926,854
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:26646455
RGD:42722616
NCBI chr10:62,789,647...62,825,651
Ensembl chr10:62,790,124...62,825,339
G
NFKBIA
NFKB inhibitor alpha
treatment exacerbates
ISO
RGD
PMID:10229101 PMID:19098124
RGD:126908017 RGD:126928139
NCBI chr24:12,211,619...12,216,185
Ensembl chr24:12,210,281...12,214,854
G
NOS2
nitric oxide synthase 2
ISO
mRNA, protein:increased expression:intestine CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12620498 PMID:16787348 PMID:20519137
RGD:4891470 RGD:5147779
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
G
NOS3
nitric oxide synthase 3
ISO
protein:increased expression:aorta (rat)
RGD
PMID:10462376
RGD:7794732
NCBI chr21:119,174,829...119,196,840
G
NPY
neuropeptide Y
treatment
ISO
RGD
PMID:15342191
RGD:1580787
NCBI chr21:34,068,533...34,076,205
Ensembl chr21:34,068,530...34,075,127
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
RGD
PMID:15640646
RGD:4892561
NCBI chr23:45,904,926...46,031,804
Ensembl chr23:45,904,873...46,031,125
G
OTC
ornithine transcarbamylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr X:35,494,334...35,570,923
Ensembl chr X:35,494,287...35,570,845
G
PCK1
phosphoenolpyruvate carboxykinase 1
ISO
RGD
PMID:12217886 PMID:19268478
RGD:10427879 RGD:625688
NCBI chr 2:6,550,806...6,556,499
Ensembl chr 2:6,549,652...6,556,478
G
PCK2
phosphoenolpyruvate carboxykinase 2, mitochondrial
ISO
mRNA,protein:decreased expression,decreased activity:liver:
RGD
PMID:19268478
RGD:10427879
NCBI chr24:1,077,206...1,087,306
Ensembl chr24:1,077,447...1,087,607
G
PCSK1
proprotein convertase subtilisin/kexin type 1
ISO
RGD
PMID:16337011
RGD:6483567
NCBI chr 4:90,246,413...90,289,148
Ensembl chr 4:90,248,598...90,289,089
G
PCSK2
proprotein convertase subtilisin/kexin type 2
ISO
RGD
PMID:16337011
RGD:6483567
NCBI chr 2:46,293,983...46,548,902
Ensembl chr 2:46,294,005...46,549,609
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
RGD
PMID:22119535
RGD:6771174
NCBI chr16:56,863,763...56,947,479
Ensembl chr16:56,880,934...56,950,999
G
PGF
placental growth factor
ISO
protein:increased expression:multiple
RGD
PMID:16702604
RGD:6483601
NCBI chr24:52,160,904...52,174,493
Ensembl chr24:52,161,787...52,173,989
G
PLA2G7
phospholipase A2 group VII
ISO
protein:increased expression: :
RGD
PMID:10748027
RGD:7248791
NCBI chr17:25,538,645...25,571,230
Ensembl chr17:25,538,438...25,574,269
G
PLAT
plasminogen activator, tissue type
treatment
ISO
RGD
PMID:9091588
RGD:11541073
NCBI chr 8:40,164,391...40,196,627
Ensembl chr 8:40,163,891...40,196,555
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:small intestine mucosa
RGD
PMID:21641970
RGD:5135029
NCBI chr22:48,262,743...48,407,415
Ensembl chr22:48,275,600...48,407,418
G
PRKAA1
protein kinase AMP-activated catalytic subunit alpha 1
ISO
mRNA:decreased expression:epididymal fat pad
RGD
PMID:20421294
RGD:6484543
NCBI chr 4:39,516,307...39,553,627
G
PRKN
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:liver, mitochondrion (mouse)
RGD
PMID:28615325
RGD:13432559
NCBI chr13:88,856,056...90,329,379
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:18205901 PMID:23170801
RGD:11100030 RGD:11100034
NCBI chr10:2,789,227...2,799,783
Ensembl chr10:2,789,277...2,799,531
G
PTAFR
platelet activating factor receptor
treatment
ISO
RGD
PMID:2178565
RGD:10041063
NCBI chr20:104,627,591...104,658,840
Ensembl chr20:104,657,179...104,658,207
G
PTGER4
prostaglandin E receptor 4
ISO
protein:increased expression:paraventricular hypothalamic nucleus parvicellular division (rat)
RGD
PMID:11058222
RGD:10043329
NCBI chr 4:39,440,697...39,453,983
Ensembl chr 4:39,440,276...39,454,004
G
PTGIS
prostaglandin I2 synthase
treatment
ISO
RGD
PMID:11076704
RGD:401960076
NCBI chr 2:14,420,318...14,484,667
Ensembl chr 2:14,441,983...14,488,264
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:21641970
RGD:5135029
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
G
REN
renin
ISO
protein:increased activity:blood plasma (rat) protein:increased activity:blood plasma (mouse)
RGD
PMID:16512638 PMID:30027346
RGD:125097481 RGD:125097499
NCBI chr25:25,159,816...25,193,620
Ensembl chr25:25,183,037...25,193,420
G
SERPINC1
serpin family C member 1
treatment
ISO
RGD
PMID:15995859 PMID:16457847 PMID:20519137 PMID:21396682
RGD:1599326 RGD:1599332 RGD:5147765 RGD:5147779
NCBI chr25:55,271,823...55,289,855
G
SERPINE1
serpin family E member 1
treatment
ISO
RGD
PMID:21396682 PMID:25396762
RGD:10449434 RGD:5147765
NCBI chr28:12,047,520...12,060,662
Ensembl chr28:12,047,529...12,060,202
G
SERPINF1
serpin family F member 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12386642
RGD:36174005
NCBI chr16:1,408,453...1,424,197
G
SERPING1
serpin family G member 1
treatment
ISO
RGD
PMID:18652771
RGD:8661643
NCBI chr 1:15,617,122...15,634,540
Ensembl chr 1:15,616,674...15,633,855
G
SLC18A3
solute carrier family 18 member A3
ISO
protein:decreased expression:parietal cortex
RGD
PMID:17306796
RGD:5686693
NCBI chr 9:42,216,187...42,219,665
Ensembl chr 9:42,216,568...42,218,166
G
SLC22A1
solute carrier family 22 member 1
treatment
ISO
RGD
PMID:18313662
RGD:7243881
NCBI chr13:87,744,600...87,780,846
Ensembl chr13:87,745,023...87,781,073
G
SLC22A2
solute carrier family 22 member 2
treatment
ISO
RGD
PMID:18313662
RGD:7243881
NCBI chr13:87,835,077...87,881,410
Ensembl chr13:87,833,430...87,881,081
G
SLC38A3
solute carrier family 38 member 3
ISO
RGD
PMID:20036385
RGD:9999227
NCBI chr22:11,591,680...11,606,291
Ensembl chr22:11,591,717...11,606,355
G
SLC38A5
solute carrier family 38 member 5
ISO
RGD
PMID:20036385
RGD:9999227
NCBI chr X:45,588,992...45,598,771
G
SLC7A5
solute carrier family 7 member 5
ISO
RGD
PMID:26337286
RGD:151361133
NCBI chr 5:73,229,953...73,269,801
Ensembl chr 5:73,229,951...73,269,754
G
SLPI
secretory leukocyte peptidase inhibitor
ISO
RGD
PMID:25466948
RGD:9999425
NCBI chr 2:18,579,549...18,581,897
Ensembl chr 2:18,579,515...18,582,076
G
SOCS1
suppressor of cytokine signaling 1
ISO
mRNA:increased expression:liver, skeletal muscle
RGD
PMID:15169905
RGD:2298923
NCBI chr 5:10,731,866...10,733,745
Ensembl chr 5:10,732,350...10,732,991
G
SOCS3
suppressor of cytokine signaling 3
ISO
mRNA:increased expression:liver, skeletal muscle
RGD
PMID:12217886 PMID:15169905
RGD:2298923 RGD:625688
NCBI chr16:70,353,099...70,356,401
Ensembl chr16:70,354,746...70,355,423
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
G
SPARC
secreted protein acidic and cysteine rich
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:10703670
RGD:2300026
NCBI chr23:54,224,003...54,248,869
Ensembl chr23:54,222,838...54,238,006
G
TBXAS1
thromboxane A synthase 1
ISO
RGD
PMID:15647606
RGD:1601450
NCBI chr21:108,584,458...108,779,357
Ensembl chr21:108,628,570...108,779,163
G
TDO2
tryptophan 2,3-dioxygenase
severity
ISO
RGD
PMID:24930766
RGD:39939032
NCBI chr 7:102,467,075...102,485,434
Ensembl chr 7:102,467,640...102,485,394
G
TFPI
tissue factor pathway inhibitor
treatment
ISO
RGD
PMID:17537762
RGD:11062086
NCBI chr10:73,004,762...73,105,772
Ensembl chr10:73,002,522...73,105,858
G
THBD
thrombomodulin
ISO
mRNA:decreased expression:endothelial cell
RGD
PMID:12611420 PMID:19487933 PMID:20348393
RGD:1601652 RGD:5684988 RGD:5685037
NCBI chr 2:52,041,950...52,045,946
Ensembl chr 2:52,043,746...52,045,626
G
TIMP3
TIMP metallopeptidase inhibitor 3
ISO
RGD
PMID:17083784
RGD:2290426
NCBI chr19:15,621,609...15,684,118
Ensembl chr19:15,622,431...15,680,449
G
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:22172266
RGD:7241094
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
G
TLR4
toll like receptor 4
treatment disease_progression
ISO
mRNA:increased expression:liver:
RGD
PMID:22172266 PMID:23977376
RGD:14697731 RGD:7241094
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
G
TNF
tumor necrosis factor
treatment
ISO
protein:increased expression:plasma (rat) associated with liver cirrhosis XCO:0000822 JTE-607
RGD
PMID:8283134 PMID:10493164 PMID:12813371 PMID:15242491 PMID:17324147 PMID:18078960 PMID:20519137 PMID:21396682 More...
RGD:14995427 RGD:14995443 RGD:15023464 RGD:38501090 RGD:40903016 RGD:4891465 RGD:5147765 RGD:5147779
G
TREM1
triggering receptor expressed on myeloid cells 1
treatment
ISO
RGD
PMID:15585833 PMID:21507332
RGD:126925982 RGD:126928122
NCBI chr17:30,873,647...30,885,292
Ensembl chr17:30,873,666...30,886,967
G
VCAM1
vascular cell adhesion molecule 1
ISO
mRNA:increased expression:brain:
RGD
PMID:20061033
RGD:7240511
NCBI chr20:32,616,425...32,635,903
Ensembl chr20:32,615,333...32,635,862
G
VWF
von Willebrand factor
ISO
protein:increased expression:endothelial cell:
RGD
PMID:2650559
RGD:11079230
NCBI chr11:5,994,499...6,176,949
Ensembl chr11:5,994,039...6,162,260
G
GCH1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:8602831
RGD:329961578
NCBI chr24:32,029,997...32,079,656
Ensembl chr24:32,027,648...32,079,490
G
HTR2A
5-hydroxytryptamine receptor 2A
treatment
ISO
RGD
PMID:19318092
RGD:401901206
NCBI chr 3:24,820,029...24,884,472
Ensembl chr 3:24,820,035...24,883,432
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all